Invention Grant
- Patent Title: Antibodies to the B12-transcobalamin receptor
-
Application No.: US14800429Application Date: 2015-07-15
-
Publication No.: US09834612B2Publication Date: 2017-12-05
- Inventor: Edward V. Quadros , Jeffrey M. Sequeira
- Applicant: The Research Foundation of State University of New York
- Applicant Address: US NY Albany
- Assignee: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
- Current Assignee: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
- Current Assignee Address: US NY Albany
- Agency: Heslin Rothenberg Farley & Mesiti PC
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; G01N33/82 ; A61K38/16 ; A61K47/68
Abstract:
The present invention provides anti-TCblR antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer, tumors and other proliferative diseases and disorders.
Public/Granted literature
- US20160130354A1 ANTIBODIES TO THE B12-TRANSCOBALAMIN RECEPTOR Public/Granted day:2016-05-12
Information query
